Massive benefits for patients at risk of CHD in largest lipid-lowering trial

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1317, 2001-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Consider lipid-lowering therapy for patients with diabetes and hyperlipidaemia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Patients are less likely to receive lipid-lowering drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Multiple Lipid-lowering Treatment in Pediatric Patients with Hyperlipidemia

Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. : 1171-1181

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-lowering Drug Therapy in Elderly Patients

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 877-893

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-Lowering Therapy in Patients with Average Cholesterol and High Cardiovascular Risk, Insights from the Heart Protection Study

By Salam Amar

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 387-389

Springer Publishing Company

Access to resources Recommend Favorite